China Healthcare Contract Manufacturing Market Size & Outlook
The healthcare contract manufacturing market in China is expected to reach a projected revenue of US$ 76,208.5 million by 2033. A compound annual growth rate of 13% is expected of China healthcare contract manufacturing market from 2025 to 2033.
China healthcare contract manufacturing market highlights
The China healthcare contract manufacturing market generated a revenue of USD 25,867.0 million in 2024 and is expected to reach USD 76,208.5 million by 2033.
The China market is expected to grow at a CAGR of 13% from 2025 to 2033.
In terms of segment, pharmaceutical was the largest revenue generating type in 2024.
Medical Devices is the most lucrative type segment registering the fastest growth during the forecast period.
Healthcare contract manufacturing market data book summary
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China healthcare contract manufacturing market is projected to lead the regional market in terms of revenue in 2033.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 76,208.5 million by 2033.
In 2016, as part of Marketing Authorization Holder (MAH) system reforms, China FDA legalized contract manufacturing, thus allowing domestic biopharmaceutical & pharmaceutical companies’ access to contract manufacturers, which is anticipated to fuel the market growth.
In addition, presence of EMA- and/or FDA-approved facilities in the country is also anticipated to increase foreign investments. For instance, nearly 92 contract service organizations have headquarters in Jiangsu with 72% of the facilities having EMA and/or FDA approval.
China Healthcare Contract Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Healthcare Contract Manufacturing Market Outlook will help companies and investors design strategic landscapes.
Pharmaceutical was the largest segment with a revenue share of 87.03% in 2024.
Horizon Databook has segmented the China healthcare contract manufacturing market based on pharmaceutical, medical devices covering the revenue growth of each sub-segment from 2021 to 2033.
In 2016, as part of Marketing Authorization Holder (MAH) system reforms, China FDA legalized contract manufacturing, thus allowing domestic biopharmaceutical & pharmaceutical companies’ access to contract manufacturers, which is anticipated to fuel the market growth.
In addition, presence of EMA- and/or FDA-approved facilities in the country is also anticipated to increase foreign investments. For instance, nearly 92 contract service organizations have headquarters in Jiangsu with 72% of the facilities having EMA and/or FDA approval.
China Healthcare Contract Manufacturing Market Type Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical
Medical Devices
China Healthcare Contract Manufacturing Market End Use Outlook (Revenue, USD Million , 2021-2033)
Medical Device Companies
Pharmaceutical & Biopharmaceutical Companies
Others
Reasons to subscribe to Healthcare Contract Manufacturing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Healthcare Contract Manufacturing Market Outlook databook
Our clientele includes a mix of Healthcare Contract Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Healthcare Contract Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Healthcare Contract Manufacturing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
China Healthcare Contract Manufacturing Market, 2021-2033 (US$M)